ST Pharm Co.,Ltd. (KOSDAQ:237690)
South Korea flag South Korea · Delayed Price · Currency is KRW
90,000
-1,800 (-1.96%)
Sep 11, 2026, 3:30 PM KST

ST Pharm Revenue

ST Pharm had revenue of 108.48B KRW in the quarter ending June 30, 2026, with 58.95% growth. This brings the company's revenue in the last twelve months to 386.46B, up 29.64% year-over-year. In the year 2025, ST Pharm had annual revenue of 331.68B with 21.16% growth.

Revenue (ttm)
386.46B
Revenue Growth
+29.64%
P/S Ratio
4.86
Revenue / Employee
590.01M
Employees
655
Market Cap
1.88T

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025331.68B57.93B21.16%
Dec 31, 2024273.75B-11.24B-3.94%
Dec 31, 2023284.99B35.67B14.31%
Dec 31, 2022249.32B83.68B50.52%
Dec 31, 2021165.64B41.53B33.47%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
DongKook Pharmaceutical979.60B
Huons Global846.78B
PharmaResearch603.58B
Sam Chun Dang Pharm.259.90B
BINEX157.28B
Oscotec144.18B
CG Invites30.11B
Mezzion Pharma8.43B
Revenue Rankings